| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Athira Pharma, Inc. | General Counsel and CCO | Common Stock | 13,978 | $96,168 | $6.88 | 02 Jan 2026 | Direct |
| Athira Pharma, Inc. | General Counsel and CCO | Restricted Stock Units | 0 | $32,176 | $0.5619 | 31 Dec 2025 | Direct |
| Athira Pharma, Inc. | General Counsel and CCO | Stock Option (Right to Buy) | 34,358 | 24 Dec 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ATHA | Athira Pharma, Inc. | 31 Dec 2025 | 3 | -$6,027 | 4 | General Counsel and CCO | 05 Jan 2026, 19:49 |
| ATHA | Athira Pharma, Inc. | 24 Dec 2025 | 1 | $0 | 4 | General Counsel and CCO | 29 Dec 2025, 16:12 |
| ATHA | Athira Pharma, Inc. | 30 Jun 2025 | 3 | -$2,502 | 4 | General Counsel and CCO | 02 Jul 2025, 16:33 |
| ATHA | Athira Pharma, Inc. | 03 Mar 2025 | 2 | $0 | 4 | General Counsel and CCO | 04 Mar 2025, 16:28 |
| ATHA | Athira Pharma, Inc. | 31 Dec 2024 | 4 | -$2,774 | 4 | General Counsel and CCO | 03 Jan 2025, 17:00 |
| ATHA | Athira Pharma, Inc. | 01 Oct 2024 | 2 | $0 | 4 | General Counsel and CCO | 03 Oct 2024, 19:08 |
| ATHA | Athira Pharma, Inc. | 03 Sep 2024 | 3 | +$11,971 | 4 | GENERAL COUNSEL | 05 Sep 2024, 19:48 |
| ATHA | Athira Pharma, Inc. | 14 Feb 2024 | 1 | $0 | 4 | GENERAL COUNSEL | 16 Feb 2024, 17:01 |
| ATHA | Athira Pharma, Inc. | 04 Jan 2024 | 3 | +$11,700 | 4/A | GENERAL COUNSEL | 16 Feb 2024, 16:37 |
| ATHA | Athira Pharma, Inc. | 04 Jan 2024 | 3 | +$11,700 | 4 | General Counsel | 08 Jan 2024, 16:38 |
| ATHA | Athira Pharma, Inc. | 19 Jan 2023 | 1 | $0 | 4 | General Counsel | 23 Jan 2023, 16:55 |
| ATHA | Athira Pharma, Inc. | 22 Jun 2022 | 3 | +$16,944 | 4 | General Counsel | 24 Jun 2022, 19:55 |
| ATHA | Athira Pharma, Inc. | 18 Jan 2022 | 1 | $0 | 4 | General Counsel | 20 Jan 2022, 16:27 |
| ATHA | Athira Pharma, Inc. | 03 Nov 2021 | 1 | $0 | 4 | General Counsel | 05 Nov 2021, 17:03 |
| ATHA | Athira Pharma, Inc. | 01 Jun 2021 | 0 | $0 | 3 | General Counsel | 01 Jun 2021, 18:32 |